Tulisokibart is a tumor necrosis factor–like cytokine 1A (TL1A) monoclonal antibody in development for the treatment of moderately to severely active ulcerative colitis. A genetic-based diagnostic ...
Association Between Medicaid Coverage Continuity and Survival in Patients With Newly Diagnosed Pediatric and Adolescent Cancers We searched ClinicalTrials.gov for phase I cancer trials of new drugs ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results